Could there possibly be one good thing about having Fibromyalgia?
Well, an interesting read in Pro Health say that according to a newly published study in the Journal of Advances in Medicine and Medical Research, there’s finally an advantage to living with fibromyalgia. Researchers from the University of Illinois College of Medicine at Chicago and biomedical firm EpicGenetics have confirmed fibromyalgia patients are much less likely to die from COVID-19 or develop severe complications from it than the general public.
During a screening, only 82 out of 2,195 fibromyalgia patients tested positive for COVID-19 antibodies. And only one of those 82 individuals was hospitalized and placed on a ventilator for severe COVID-19 infection.
“According to the CDC (Centers for Disease Control and Prevention), a total of 63,152 laboratory-confirmed COVID-19 associated hospitalizations per day were reported between March 1, 2020 and October 17, 2020,” reads the study. “The overall cumulative hospitalization rate was 193.7 per 100,000 population. Using those numbers, we would have expected far more than just one person in our cohort to have required a hospitalization but that did not transpire.”
Pro Health wrote even more shocking, there were no COVID-19 deaths among the cohort of fibromyalgia patients.
Apparently fibromyalgia patients’ immune systems are deficient in two particular cytokines, IL-6 and IL-8, and those two cytokines just happen to be the same ones that rage out of control during severe COVID-19 infections.